Progress in Neurotherapeutics and Neuropsychopharmacology

by Edited by Jeffrey L. Cummings

• ISBN13: 9780521115612
• ISBN10: 0521115612
• Edition: 1st
• Format: Paperback
• Copyright: 2009-08-27
• Publisher: Cambridge University Press

Summary

Published annually, volumes in this series provide readers with updates of recent clinical trial results, impacts of trials on guidelines and evidence-based practice, advances in trial methodologies, and the evolution of biomarkers in trials. The series focuses on trials in neurotherapeutics, including disease-modifying and symptomatic agents for neurological diseases, psychopharmacological management of neurologic and psychiatric illnesses, and non-drug treatments. Each paper is authored by a leader in the area of neurotherapeutics and clinical trials, and the series is guided by an editor-in-chief and editorial board with broad experience in drug development and neuropsychopharmacology. Progress in Neurotherapeutics and Neuropsychopharmacology is an essential update of recent trials in all aspects of the management of neurologic and neuropsychiatric disorders, and will be an invaluable resource for practising neurologists as well as clinical and translational neuroscientists.

Table of Contents

Contributors

Progress in neurotherapeutics and neuropsychopharmacology

Trifusal versus aspirin for the prevention of stroke Antonio Culebras

The Argatroban and tPA stroke study

Use of Selegiline as monotherapy and in combination with Levodopa in the management of Parkinson's disease: perspectives from the MONOCOMB study

Ropinirole 24-h prolonged release in advanced Parkinson's disease: review of a randomised, double-blind, placebo-controlled study (EASE PD - adjunct study)

Insulin resistance and Alzheimer's disease: pathophysiology and treatment

Targeting Amyloid with Tramiprosate in patients with mild-to-moderate Alzheimer's disease

Intranasal Zolmitriptan is effective and well-tolerated in acute cluster headache: a randomized placebo-controlled double-blind crossover

Optimal dosing of immunomodulating drugs: a dose-comparison study of GA in RRMS

Tetrathiomolybdate versus Trientine in the initial treatment of neurologic Wilson's disease

Randomized clinical trials of Pregabalin for neuropathic pain: methods, results, and implications

Effect of Methylphenidate in patients with acute traumatic brain injury: a randomized clinical trial

Improvement in speeded cognitive processing after anti-epileptic drug withdrawal - a controlled study in mono-therapy patients

A randomized-controlled trial of bilateral rTMS for treatment-resistant depression

Serotonin related genes affect antidepressant treatment in obsessive-compulsive disorder

Night eating syndrome and results from the first placebo-controlled trial of treatment, with the SSRI medication, Sertraline: implications for clinical practice

Modafinil: a candidate for pharmacotherapy of negative symptoms in schizophrenia

New approaches to treatment of schizophrenia by enhancing N-methyl-D-aspartate neurotransmission

Subject index

Author index

Table of Contents provided by Publisher. All Rights Reserved.